Method of determining pregnanediol in female urine and test device for use therein
First Claim
Patent Images
1. The method of determining the concentration of pregnanediol glucuronide (PG) in a female, comprising:
- (a) adding to a measured sample of said urine a predetermined quantity of antibodies binding to PG, said antibodies being labeled with a substance capable of providing a visual color indication;
(b) contacting the reacted urine sample with a predetermined quantity of a 20-α
reagent immobilized on a color indicator support, said reagent consisting essentially of 20α
-hydroxy-4-pregnen-3-one, the unreacted labeled antibodies from said urine binding to said 20-α
reagent on said support; and
(c) determining from the intensity of color developed the concentration of PG in the urine sample.
1 Assignment
0 Petitions
Accused Products
Abstract
A method is provided for determining the concentration of pregnanediol glucuronide (PG) in a woman'"'"'s urine which is characterized by utilization of the reagent 20α-hydroxy-4-pregnen-3-one (20-α reagent) in a form in which it reacts with antibodies binding to PG. The method is adaptable to a visual color indication test which can be performed by the woman herself as well as by laboratory analysis. The method can be used to define the period in which conception can occur, to define a post-ovulation safe period in which conception is prevented, and as an early pregnancy indicator.
22 Citations
13 Claims
-
1. The method of determining the concentration of pregnanediol glucuronide (PG) in a female, comprising:
-
(a) adding to a measured sample of said urine a predetermined quantity of antibodies binding to PG, said antibodies being labeled with a substance capable of providing a visual color indication; (b) contacting the reacted urine sample with a predetermined quantity of a 20-α
reagent immobilized on a color indicator support, said reagent consisting essentially of 20α
-hydroxy-4-pregnen-3-one, the unreacted labeled antibodies from said urine binding to said 20-α
reagent on said support; and(c) determining from the intensity of color developed the concentration of PG in the urine sample. - View Dependent Claims (2, 3, 4, 5, 6, 7)
-
-
8. The method of determining the concentration of pregnanediol glucuronide (PG) in a woman'"'"'s urine, comprising:
-
(a) adding to a measured sample of said urine a predetermined quantity of a 20-α
reagent, said reagent consisting essentially of 20α
-hydroxy-4-pregnen-3-one and being labeled with a substance capable of providing a visual color indication;(b) contacting the reacted urine with a predetermined quantity of antibodies binding to PG immobilized on a color indicator support, said labeled 20-α
reagent and said PG reacting competitively with said antibodies; and(c) determining from the intensity of color developed the concentration of PG in the urine sample. - View Dependent Claims (9)
-
-
10. A test device for use in determining the concentration of pregnanediol glucuronide (PG) in a sample of female urine, comprising a color indicator support having immobilized thereon a known quantity of a 20-α
- reagent consisting essentially of 20α
-hydroxy-4-pregnen-3-one. - View Dependent Claims (11)
- reagent consisting essentially of 20α
-
12. A test strip for use in determining the concentration of pregnanediol glucuronide in a sample of a woman'"'"'s urine, comprising an adsorbent fibrous strip having immobilized thereon a known quantity of a 20-α
- reagent consisting essentially of 20α
-hydroxy-4-pregnen-3-one. - View Dependent Claims (13)
- reagent consisting essentially of 20α
Specification